These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 23881612

  • 21. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
    Liu LT, Chang HC, Chiang LC, Hung WC.
    Cancer Res; 2003 Jun 15; 63(12):3069-72. PubMed ID: 12810630
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. RECK is not an independent prognostic marker for breast cancer.
    Gomes LR, Fujita A, Mott JD, Soares FA, Labriola L, Sogayar MC.
    BMC Cancer; 2015 Oct 08; 15():660. PubMed ID: 26449734
    [Abstract] [Full Text] [Related]

  • 24. Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling.
    Kitajima S, Miki T, Takegami Y, Kido Y, Noda M, Hara E, Shamma A, Takahashi C.
    Oncogene; 2011 Feb 10; 30(6):737-50. PubMed ID: 20890302
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.
    Baumgart A, Seidl S, Vlachou P, Michel L, Mitova N, Schatz N, Specht K, Koch I, Schuster T, Grundler R, Kremer M, Fend F, Siveke JT, Peschel C, Duyster J, Dechow T.
    Cancer Res; 2010 Jul 01; 70(13):5368-78. PubMed ID: 20551051
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Targeting Inhibition of Notch1 Signaling Pathway on the Study of Human Gastric Cancer Stem Cells with Chemosensitization.
    Dou Y, Wang J.
    Comput Intell Neurosci; 2022 Jul 01; 2022():1098394. PubMed ID: 35515501
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries.
    Palladini G, Di Pasqua LG, Croce AC, Ferrigno A, Vairetti M.
    Int J Mol Sci; 2023 Dec 12; 24(24):. PubMed ID: 38139236
    [Abstract] [Full Text] [Related]

  • 35. Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133+ Skin Cancer Stem Cells.
    Quan XX, Hawk NV, Chen W, Coupar J, Lee SK, Petersen DW, Meltzer PS, Montemarano A, Braun M, Chen Z, Van Waes C.
    Mol Cancer Ther; 2018 Sep 12; 17(9):2034-2048. PubMed ID: 29959199
    [Abstract] [Full Text] [Related]

  • 36. Involvement of the SKP2-p27(KIP1) pathway in suppression of cancer cell proliferation by RECK.
    Yoshida Y, Ninomiya K, Hamada H, Noda M.
    Oncogene; 2012 Sep 13; 31(37):4128-38. PubMed ID: 22158033
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T, Hisanaga M, Nagao M, Ikeda N, Fujii H, Koyama F, Mukogawa T, Matsumoto H, Kondo S, Takahashi C, Noda M, Nakajima Y.
    Clin Cancer Res; 2004 Aug 15; 10(16):5572-9. PubMed ID: 15328199
    [Abstract] [Full Text] [Related]

  • 39. Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1.
    Tyagi A, Vishnoi K, Mahata S, Verma G, Srivastava Y, Masaldan S, Roy BG, Bharti AC, Das BC.
    Clin Cancer Res; 2016 Aug 15; 22(16):4170-84. PubMed ID: 26988248
    [Abstract] [Full Text] [Related]

  • 40. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
    Liu LT, Chang HC, Chiang LC, Hung WC.
    Oncogene; 2002 Nov 28; 21(54):8347-50. PubMed ID: 12447698
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.